💨 Abstract

Bioventus Inc. reported a loss of $2.6 million in the first quarter of 2025, with a per-share loss of 4 cents. Adjusted earnings were 8 cents per share, and revenue was $123.9 million. The company anticipates full-year earnings to range from 64 cents to 68 cents per share, with revenue between $560 million to $570 million.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖